Juan W. Valle - Christie Hospital Department of Medical Oncology Wilmslow Road Manchester M20 4BX UK

基本信息

浏览量：287

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 120 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P-285 Basket trials in upper gastrointestinal and hepato-pancreatico-biliary cancers – an emerging entity

P. Huddar, K. Graham, R. Hubner,J. Valle, M. McNamara

Annals of Oncology (2023): S116-S116

引用0浏览0引用

SO-2 Quantitative risk-benefit assessment of ivosidenib compared to placebo in patients with IDH1-mutated intrahepatic cholangiocarcinoma: Phase 3 ClarIDHy trial

J. Valle, G. Abou-Alfa,R. Kelley, M. Lowery, R. Shroff, Y. Bian, G. Saint-Hilary, H. Liu, Z. Teng, Z. Hua, C. Gliser, A. Vogel,

Annals of Oncology (2023): S162-S162

引用0浏览0引用

106P The impact of alterations in cancer driver genes and other potentially targetable mutations on progression and overall survival in patients with biliary tract cancer treated on the randomised phase III multicentre BILCAP clinical trial

V.E. Crolley,R. Guest,A.D. Beggs, E. Jaynes, S. Thorn,J. Herrero, I. Tomlinson,J.W. Valle,J.N. Primrose,J.A. Bridgewater

Annals of Oncology (2023): S222-S222

引用0浏览0引用

P-22 Frequency of dihydropyrimidine dehydrogenase (DPD) deficiency detection and adverse events in patients receiving fluoropyrimidine-based therapy in a pancreatic and biliary tract cancer cohort

E. Wilson, P. Monaghan, J. Gleeson, A. Lamarca, R. Hubner,J. Valle,M. McNamara

Annals of Oncology (2023): S21-S21

引用0浏览0引用

Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer

Do-Youn Oh,Aiwu Ruth He,Shukui Qin,Li-Tzong Chen,Takuji Okusaka,Arndt Vogel,Jin Won Kim,Thatthan Suksombooncharoen,Myung Ah Lee,Masayuki Kitano,Howard Burris,Mohamed Bouattour,

FUTURE ONCOLOGYno. 34 (2023): 2277-2289

引用0浏览0WOS引用

Abstract CT008: Pembrolizumab (pembro) in combination with gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC): Phase 3 KEYNOTE-966 study

Robin Kate Kelley,Changhoon Yoo,Richard S. Finn,Junji Furuse,Zhenggang Ren,Thomas Yau,Heinz‐Josef Klümpen,Stephen L. Chan,Arndt Vogel,Masato Ozaka,Chris Verslype, M. Benameur,

Cancer Researchno. 8_Supplement (2023): CT008-CT008

引用0浏览0引用

Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer

F. Finkelmeier,M. Bouattour,J. W. Valle,A. Vogel,J. W. Kim,M. Kitano, J. -S. Chen,H. Burris,R. Zaucha, S. Qin, L. Evesque,D. B. Zhen,

Journal of Clinical Oncologyno. 4_suppl (2023): 127-128

引用1浏览0引用

Impact of mutation status on efficacy outcomes in TOPAZ-1: A Phase 3 study of Durvalumab (D) or Placebo (PBO) plus Gemcitabine and Cisplatin ( plus GC) in advanced Biliary Tract Cancer (BTC)

A. Vogel,J. Valle, S. Qin, L. Antonuzo, D. Tougeron, C. -K. Lee, B. Tan, M. Ikeda, V. Guthrie, P. McCoon, Y. Lee, N. Rokutanda,

ONCOLOGY RESEARCH AND TREATMENT (2023): 63-64

引用0浏览0引用

94MO Advanced extrahepatic cholangiocarcinoma: Post-hoc analysis of the ABC-01, -02 and -03 clinical trials

A. Lamarca,P.J. Ross,H.S. Wasan,R. Hubner,M.G. McNamara,A. Lopes,D. Palmer,J.W. Valle,J.A. Bridgewater

Annals of Oncology (2023): S215-S215

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn